BCL3 and neoplasm: DNA methylation analysis assigned 77% (51/66) of patients with <i>IGH</i>::<i>BCL3-</i>translocation with at least 60% tumor cell content to the naive B-cell-like group but unraveled a distinct and during follow-up stable signature resembling in part plasma cell-like epigenetic features.